Toulouse and Paris, August 31, 2020
GamaMabs is deeply saddened to learn the death of Isabelle Tabah-Fisch, its former Chief Medical Officer, on August 28.
Isabelle joined GamaMabs Pharma in November 2016 to bring us her remarkable expertise in Oncology and her high-level network which enabled her to design and implement our clinical trials, until her retirement in March 2020.
Despite the illness that affected her for two years, Isabelle displayed admirable professionalism, courage and energy.
Beyond her professional qualities, we will always remember Isabelle’s great vitality, her joie de vivre, her motivation for therapeutic progress and her ethical standards.
Our hearts go out to Isabelle’s family, especially her father and 3 children.
May Isabelle rest in peace.
